Shares in weight loss drugmaker Eli Lilly fall on disappointing sales

Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales

US group revises down upper end of full-year revenue estimates

Business - Financial Times - 11 hours ago

Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Business - CNBC - October 15

Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.

Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed

Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.

Business - CNBC - 3 hours ago

Chipotle misses revenue estimates as same-store sales growth disappoints

Chipotle's same-store sales rose 6% in the third quarter, just missing Wall Street's expectations.

Business - CNBC - 9 hours ago

ASML share plunge wipes over $50 billion off Dutch chip giant's value

ASML published its third-quarter earnings Tuesday, a day earlier than expected.

Business - CNBC - October 16

Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.

Business - MarketWatch - 4 hours ago

FDA will reconsider decision barring copycat versions of Lilly weight loss drug

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

Politics - The Hill - October 14

Lilly's weight loss drug shortage deemed over, but hurdles remain

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Jim Cramer looks at what to do with Eli Lilly, AMD shares after their big slides on earnings

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

Business - CNBC - 8 hours ago

Weight Loss Jabs for Jobs?

Health Secretary says jabs could be given to help people get back into work.

Eli Lilly's quarter was messy. What to do with the stock is more clear-cut

We're upgrading our rating on the drugmaker to a buy-equivalent 1.

Business - CNBC - 4 hours ago

Deutsche Bank shares fall on doubling of third-quarter loan losses but profits rise

Deutsche Bank’s pre-tax profits were lifted by a reduction in the provisions it has set aside to settle litigation related to its Postbank acquisition

Business - MarketWatch - October 23

L’Oréal sales disappoint due to weak Chinese demand

Revenue at world’s biggest beauty company grew 3.4 per cent in third quarter, when analysts expected 6 per cent

Business - Financial Times - October 22

Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.

Business - CNBC - 3 hours ago

Unemployed could get weight loss jabs to return to work

The health secretary announces trials to explore the effect of weight loss drugs on worklessness.

Will weight-loss drugs help jobless get back into work?

Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?

NHS needs better plan around weight loss jabs, warn experts

Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.

Weight-loss drugs show promise in tackling opioid and alcohol abuse

Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetes

World - Financial Times - October 17

Weight loss drugs could help patients struggling with addiction, study says

A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.

Weight loss drugs could help with alcohol, opioid addiction, study says

Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.

Weight loss drugs may help reduce drug and alcohol misuse: Research

Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...

Politics - The Hill - October 17

Weight loss injections: How do drugs like Wegovy and Mounjaro work?

NHS experts report unprecedented demand for the new generation of obesity treatments.

Weight-loss drugs could be key in lowering US obesity rates – experts

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts. Obesity rates have decreased slightly in the US and while it’s too early to say whether the ...

World - The Guardian - October 18

Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn

Scientists say using the drugs to get people back into work could carry logistical and ethical problems. Weight loss jabs are not a “quick fix” and the health secretary’s plan to use them to help ...

World - The Guardian - October 18

How will weight-loss drugs change our relationship with food?

The rise of these treatments has major implications for how we think about obesity, says James Gallagher.

Weight loss jabs for jobless not dystopian, says Wes Streeting

The government is looking into whether weight-loss drugs can help get more people back to work.

Latest in Shares in weight loss drugmaker Eli Lilly fall on disappointing sales